Sulfated Cyclocarya Paliurus Polysaccharide Sorchestrates the Gut Microbiome to Mobilize a Host‐Derived 12‐HEPE Against Ulcerative Colitis
Advanced Science · 2026-08 · 13 (44)
DOI: 10.1002/advs.75681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.05.2026. Verfasst von Xianxiang Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Polysaccharides, Juglandaceae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Despite extensive evidence supporting the therapeutic potential of natural product‐derived compounds in Ulcerative colitis (UC), their precise mechanisms have yet to be fully elucidated. In this study, structurally modified Cyclocarya paliurus polysaccharide (CP) derivatives were evaluated in a dextran sulfate sodium (DSS)‐induced UC mouse model. Among the variants tested, sulfated Cyclocarya paliurus polysaccharide (SCP) emerged as the most therapeutically potent. SCP administration markedly attenuated colitis severity, as evidenced by relieved disease symptoms and reinforced intestinal barrier function. Mechanistically, SCP restored gut microbial homeostasis by enriching beneficial Bacteroidetes and enhancing short‐chain fatty acids (SCFAs) production. This remodeled microbial ecosystem orchestrates the upregulation of host‐derived 12‐hydroxyeicosapentaenoic acid (12‐HEPE), which exerts anti‐inflammatory effects via direct inhibition of Toll‐like receptor 4 (TLR4) signaling. The gut microbiota's functional relevance was substantiated by fecal microbiota transplantation and antibiotic‐mediated exhaustion studies. Notably, the therapeutic benefits of 12‐HEPE were abrogated upon co‐administration of a TLR4 agonist, confirming its target specificity. Elevated serum 12‐HEPE levels were observed in a human UC cohort, implying a potential compensatory immunoregulatory response. Our findings elucidate a novel microbiota–host interaction axis wherein SCP alleviates UC by modulating the gut microbiota to enhance endogenous 12‐HEPE production, thereby suppressing TLR4‐mediated inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China.
- College of Food Science and Engineering, Hainan University, Haikou, China.
- Department of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- Department of Wood Science, The University of British Columbia, Vancouver, Canada.
ORCID-Profile: Qiang Yu, Yi Chen, Jianhua Xie
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, X., Shen, M., Zhang, R., Huang, Z., Niu, H., Yu, Q., Chen, Y., Pan, X., Rong, L., Wen, H., Yang, J., & Xie, J. (2026). Sulfated Cyclocarya Paliurus Polysaccharide Sorchestrates the Gut Microbiome to Mobilize a Host‐Derived 12‐HEPE Against Ulcerative Colitis. Advanced Science, 13(44). https://doi.org/10.1002/advs.75681
Vancouver
Chen X, Shen M, Zhang R, Huang Z, Niu H, Yu Q, et al. Sulfated Cyclocarya Paliurus Polysaccharide Sorchestrates the Gut Microbiome to Mobilize a Host‐Derived 12‐HEPE Against Ulcerative Colitis. Advanced Science. 2026;13(44). doi:10.1002/advs.75681
BibTeX
@article{Chen2026,
author = {Chen, Xianxiang and Shen, Mingyue and Zhang, Rui and Huang, Zhibing and Niu, Hui and Yu, Qiang and Chen, Yi and Pan, Xiangwen and Rong, Liyuan and Wen, Huiliang and Yang, Jun and Xie, Jianhua},
title = {Sulfated Cyclocarya Paliurus Polysaccharide Sorchestrates the Gut Microbiome to Mobilize a Host‐Derived 12‐HEPE Against Ulcerative Colitis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {44},
doi = {10.1002/advs.75681}
}
EUVIMED